This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Zhou, H. Articles by Tan, K. C. PubMed Articles by Zhou, H. Articles by Tan, K. C. Social Bookmarking                         What's this?

Impaired serum capacity to induce cholesterol efflux is associated with endothelial dysfunction in type 2 diabetes mellitus

Department of Endocrinology,The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, 310003, China

Sammy WM Shiu

Department of Medicine, University of Hong Kong, Hong Kong, China

Ying Wong

Department of Medicine, University of Hong Kong, Hong Kong, China

Kathryn CB Tan

Department of Medicine, University of Hong Kong, Hong Kong, China

Objective: Reverse cholesterol transport (RCT) plays a protective role against atherosclerosis and cholesterol efflux from cells is an early step in the RCT pathway. We investigated whether the capacity of serum to induce cholesterol efflux was associated with endothelial dysfunction in type 2 diabetes. Methods: Endothelium-dependent and -independent vasodilation of the brachial artery was measured by high-resolution vascular ultrasound and serum cholesterol efflux capacity was determined by measuring the transfer of [3H]cholesterol from Fu5AH cells to serum in 137 patients with type 2 diabetes and 75 controls. Results: Serum cholesterol efflux capacity was lower in diabetic patients than in the controls (13.6±2.5% vs. 14.6±3.4%, respectively, p=0.02), and both endothelium-dependent vasodilation (4.9±2.2% vs. 8.8±4.1%, respectively, p<0.01) and endothelium-independent vasodilation were impaired (13.4±4.3% vs. 16.3±5.5%. respectively, p<0.01). Endothelium-dependent vasodilation correlated with serum cholesterol efflux capacity (r=0.26, p=0.003) in diabetic patients and controls (r=0.24, p=0.037). On general linear model analysis, the presence of diabetes, brachial artery diameter and serum cholesterol efflux capacity were significant independent determinants of endothelium-dependent vasodilation. Conclusion: Impaired serum cholesterol efflux capacity was associated with endothelial dysfunction independent of other cardiovascular risk factors.

Key Words: serum cholesterol efflux capacity • reverse cholesterol transport • endothelial dysfunction • type 2 diabetes mellitus

Diabetes and Vascular Disease Research, Vol. 6, No. 4, 238-243 (2009)
DOI: 10.1177/1479164109344934


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?